13F-HR filed by Swiss National Bank
Swiss National Bank filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-07, with 2,505 holding rows worth $142,689,247,168.
- Accession
- 0001582202-24-000005
- Filer
- CIK 1582202
- Filed
- 2024-05-07
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 2,505 entries on the cover page, a total value of $142,689,247,168 stated on the cover page (in dollars after the unit check, H1), rows summing to $142,689,247,168 with VALUE read as dollars as filed, 13F file number 028-15577. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPIRIT AIRLS INC | 848577102 | COM | 53,800 | $260,392 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 86,600 | $245,944 | dollars as filed | |
| PAMT CORP | 693149106 | COMMON STOCK | 13,015 | $210,973 | dollars as filed | |
| ENTRAVISION COMMUNICATIONS A | 29382R107 | COMMON STOCK | 123,950 | $203,278 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 20,575 | $66,869 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001582202-24-000005 | this filing | 2024-05-07 | acceptance time not in the bulk data set |